Ignite Creation Date:
2024-05-05 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00389285
Status:
COMPLETED
Last Update Posted:
2009-05-27
First Post:
2006-10-16
Brief Title:
Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma
Sponsor:
ZymoGenetics
Organization:
ZymoGenetics
Organization Data
Organization:
ZymoGenetics
Class:
INDUSTRY
Study ID:
494F01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ZymoGenetics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Naomi Hunder Medical Monitor
Old Organization:
ZymoGenetics Inc